We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Integrated Workstation Combines Immunoassay Systems and Chemistry Analyzers

By Biotechdaily staff writers
Posted on 29 Jun 2007
An integrated workstation combines immunoassay testing and clinical chemistry in one instrument.

The closed-tube aliquotting (CTA) platform serves as a single point of entry for the integrated system. More...
Samples are automatically aliquoted and routed through immunologic and chemical test platforms without the need to split samples or cap and re-cap tubes. The immunoassay system combines chemiluminescence technology with a large menu of tests for cancer management, cardiac disease, thyroid function, and other critical diagnostic assays. The routine chemistry tests include glucose, cholesterol, electrolytes, triglycerides, and proteins.

Integrated systems, such as Beckman Coulter's (Fullerton, CA, USA; www.beckmancoulter.com) new DxC 880i Synchron Access Clinical System, provide consolidation of chemistry and immunoassay testing to improve turnaround times and lab efficiency; identical reagents and consistent results in the Unicel family of instruments; system software that is similar across all testing platforms; and common data management to organize and track information. The DxC 880i was launched at the EuroMedLab conference in Amsterdam (The Netherlands) in June 2007. The instrument was developed for high-throughput laboratories.

Built with the same technology used in the DxI 800, the DxI 800i was designed to reduce costs and optimize labor resources. The UniCel family of systems is flexible, productive, and safe. Laboratories using DxC 800 and DxI 800 will be able to upgrade the analyzers in the DxC 880i in 2008. More cross-platform configurations are being developed.


Related Links:
Beckman Coulter

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.